Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Nurse and allied solutions | 3,982.5 | 2,990.1 | 1,699.3 | 1,562.6 | 1,431.0 | 1,238.5 | | 953.3 |
Other workforce solutions | | | | | | 319.3 | | 124.7 |
Locum tenens solutions | 428.1 | 352.7 | 277.4 | 324.7 | | 430.6 | | 385.1 |
Other | 832.7 | 641.5 | 417.0 | 334.9 | 705.1 | | | |
Total revenues | 5,243.2 | 3,984.2 | 2,393.7 | 2,222.1 | 2,136.1 | 1,988.5 | 1,902.2 | 1,463.1 |
Revenue growth [+] | 31.6% | 66.4% | 7.7% | 4.0% | 7.4% | 4.5% | 30.0% | 41.2% |
Nurse and allied solutions | 33.2% | 76.0% | 8.7% | 9.2% | 15.5% | | | |
Locum tenens solutions | 21.4% | 27.1% | -14.5% | | | | | |
Cost of goods sold | 3,526.6 | 2,674.6 | 1,601.9 | 1,478.6 | 1,439.7 | 1,344.0 | 1,282.5 | 993.7 |
Gross profit | 1,716.7 | 1,309.6 | 791.8 | 743.5 | 696.4 | 644.4 | 619.7 | 469.4 |
Gross margin | 32.7% | 32.9% | 33.1% | 33.5% | 32.6% | 32.4% | 32.6% | 32.1% |
Selling, general and administrative | 936.6 | 730.5 | 549.7 | 508.0 | 452.3 | 399.7 | 398.5 | 319.5 |
EBITDA [+] | 784.2 | 581.7 | 243.5 | 235.4 | 244.1 | 244.7 | 221.3 | 149.8 |
EBITDA growth | 34.8% | 138.9% | 3.4% | -3.5% | -0.3% | 10.6% | 47.7% | 78.6% |
EBITDA margin | 15.0% | 14.6% | 10.2% | 10.6% | 11.4% | 12.3% | 11.6% | 10.2% |
Depreciation | 54.0 | 40.7 | 94.2 | 58.5 | 41.2 | 32.3 | 29.6 | 21.0 |
EBITA | 730.2 | 541.0 | 149.3 | 176.9 | 202.8 | 212.4 | 191.6 | 128.9 |
EBITA margin | 13.9% | 13.6% | 6.2% | 8.0% | 9.5% | 10.7% | 10.1% | 8.8% |
Amortization of intangibles | 83.1 | 63.0 | | | | | | |
EBIT [+] | 647.1 | 478.0 | 149.3 | 176.9 | 202.8 | 212.4 | 191.6 | 128.9 |
EBIT growth | 35.4% | 220.2% | -15.6% | -12.8% | -4.5% | 10.9% | 48.7% | 89.8% |
EBIT margin | 12.3% | 12.0% | 6.2% | 8.0% | 9.5% | 10.7% | 10.1% | 8.8% |
Interest expense | 40.4 | 34.1 | 57.7 | 28.4 | 16.1 | 19.7 | 15.5 | 7.8 |
Interest expense | 40.4 | 34.1 | 57.7 | 28.4 | 16.1 | 19.7 | 15.5 | 7.8 |
Pre-tax income | 606.7 | 443.9 | 91.5 | 148.5 | 186.7 | 192.8 | 176.2 | 121.1 |
Income taxes | 162.7 | 116.5 | 20.9 | 34.5 | 44.9 | 60.2 | 70.3 | 39.2 |
Tax rate | 26.8% | 26.3% | 22.8% | 23.2% | 24.1% | 31.2% | 39.9% | 32.4% |
Net income | 606.7 | 443.9 | 91.5 | 114.0 | 141.7 | 132.6 | 105.8 | 81.9 |
Net margin | 11.6% | 11.1% | 3.8% | 5.1% | 6.6% | 6.7% | 5.6% | 5.6% |
|
Basic EPS [+] | $13.61 | $9.31 | $1.93 | $2.44 | $2.99 | $2.77 | $2.21 | $1.72 |
Growth | 46.2% | 382.4% | -20.9% | -18.4% | 7.9% | 25.6% | 28.1% | 141.2% |
Diluted EPS [+] | $13.52 | $9.24 | $1.92 | $2.40 | $2.91 | $2.68 | $2.15 | $1.68 |
Growth | 46.3% | 381.5% | -19.9% | -17.8% | 8.6% | 24.8% | 28.1% | 142.7% |
|
Shares outstanding (basic) [+] | 44.6 | 47.7 | 47.4 | 46.7 | 47.4 | 47.8 | 47.9 | 47.5 |
Growth | -6.5% | 0.6% | 1.5% | -1.4% | -0.9% | -0.3% | 0.9% | 2.2% |
Shares outstanding (diluted) [+] | 44.9 | 48.0 | 47.7 | 47.6 | 48.7 | 49.4 | 49.3 | 48.8 |
Growth | -6.6% | 0.7% | 0.2% | -2.2% | -1.5% | 0.3% | 0.9% | 1.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|